The free event will be held March 1 at Railroad Park and includes a 5K and fun run.

New guidelines create clarity of language that will help advance mitochondria transfer and transplantation research for therapeutic innovations.

As part of the Department of Genetics' roundtable discussion series, two faculty members will share insights into their research, the inspirations behind their work, and the potential impact of their findings on the future. The discussion features assistant professors Zhangli Su, Ph.D., and Jia Xu, Ph.D.  Zhangli Su, Ph.D.

As part of the Department of Genetics' roundtable discussion series, two faculty members will share insights into their research, the inspirations behind their work, and the potential impact of their findings on the future. The discussion features assistant professors Coral Wille, Ph.D., and Arko Sen, Ph.D.

The UAB Heersink School of Medicine proudly announces that John Hartman, M.D., has been awarded a three-year research grant from the Cystic Fibrosis Foundation (CFF). This grant recognizes Hartman’s work in developing genetic strategies to restore the function of the CFTR protein, which is defective in individuals with cystic fibrosis.

This polygenic score predicts tamoxifen treatment resistance is better than conventional methods, with potential for personalized medicine application.

In Fall 2024, UAB Heersink School of Medicine announced the winners of the 2024 Dale J. Benos Medical Student Research Day (MSRD).

Associate Dean for Genomic Medicine and Distinguished Professor of Genetics, Bruce Korf, M.D., Ph.D., FACMG, retired on September 30, 2024, after over 40 years of dedicated service, and over 20 years at the University of Alabama at Birmingham (UAB).

Anindya Dutta, MBBS, Ph.D., chair of the Department of Genetics, will be honored as the 2025 recipient of the American Society for Investigative Pathology (ASIP) Rous-Whipple Award.

UAB researchers are pioneering five new projects as they continue making new discoveries and advancing science to benefit oral health locally and globally.

Graduate Biomedical Sciences (GBS) at UAB recently welcomed its new class of GBS students pursuing their Ph.D. across eight interdisciplinary training themes.

Heersink School of Medicine awarded nine staff members as the 2024 Dean’s Excellence Awards for Staff winners. Individuals selected for this honor showcased outstanding accomplishments beyond their daily duties and contributed considerably to Heersink’s core mission areas – education, clinical care, and basic, translational, and clinical research.

Starlette Jones Dabbs, Joint Health Sciences Administrator III of Precision Medicine, Genomics and Genetics, has been named a recipient of the Dean’s Excellence Awards for Staff.

UAB has committed to a significant leap forward in biomedical research by approving the Center for Integrative Structural Biology during the June 2024 University of Alabama System Board of Trustees meeting.

As part of the Department of Genetics’ series of roundtable discussions, two faculty members are taking time out of their schedules to discuss their particular areas of research, their inspirations for the work that they do, and how they hope their research will impact the future. Our first discussion is between assistant professors Chen Huang, Ph.D., and Bo-Kuan Wu, Ph.D.

This devastating neurodevelopmental disorder has no currently approved treatments.

Cassandra Newsom, Psy.D., director of the Translational Research Core in Autism and Neurodevelopment of Civitan International Research Center, has completed participation in Phase 2 Clinical Trials of a new drug, NNZ-2591, that shows promising results for a devastating neurodevelopmental disorder called Pitt-Hopkins Syndrome (PTHS).

Seven chief residents at UAB recently graduated from the Chief Residents Leadership Series Spring 2024 program. The program, presented by UAB Medicine’s Leadership Development Office, recognized its graduates at a ceremony on May 30, 2024.

A platform for undergraduate students to advance their research, the UAB Summer Research Academy (SRA) launched its seventh installment of the program on June 3, 2024. This competitive research program provides summer scholarships for students in the joint health sciences while preparing them for advancement to graduate or medical scientist training programs.

Yuva Biosciences, a startup company founded by Keshav K. Singh, Ph.D., professor in the Department of Genetics, has secured $7.5 million in seed funding that will be invested in resources aiming to restore mitochondrial dysfunction for multiple indications while helping to combat hair loss.

The spring 2024 Endowed Chairs and Professorships Reception honored the distinguished faculty members of the Heersink School of Medicine for their outstanding impact on contemporary medicine and medical education. Anupam Agarwal, M.D., the dean of the Heersink School of Medicine, extended a warm welcome to the honorees, their families, and other leaders from the school.

The Heersink School of Medicine Office for Diversity and Inclusion hosted the annual Women in Medicine and Science Promotion Reception April 11, which recognized women faculty promoted at the end of 2023. The honorees and their guests were greeted by Heersink leadership to celebrate their remarkable achievements.

A new artificial intelligence center will bring more discovery in the field to UAB.

Professor Ludwine Messiaen, Ph.D., a long-term faculty member of the Department of Genetics who established and directed the Medical Genomics Laboratory at the University of Alabama at Birmingham (UAB), has passed away. Our deepest condolences go out to her family, friends, and colleagues.

The award is the highest honor given by the ACMG Foundation for Genetic and Genomic Medicine.

Bruce Korf, M.D., Ph.D., FACMG, Associate Dean for Genomic Medicine and Distinguished Professor of Genetics at the University of Alabama at Birmingham (UAB), has been named the recipient of the 2024 American College of Medical Genetics (ACMG) Foundation for Genetic and Genomic Medicine’s David L. Rimoin Lifetime Achievement Award in Medical Genetics.

The UAB Marnix E. Heersink School of Medicine is pleased to announce the newest cohort of James A.

Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.

The clinically approved drug ruxolitinib suppressed a mouse model of melanoma that is resistant to immune checkpoint blockers.

In response to a viral infection, intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling, leading to different fates for two subsets of those cells — the one producing IL-2 and the one not producing IL-2.